Zoekresultaten - 21 results
Methods for meta-analysis and meta-regression of binomial data: concepts and tutorial with Stata command metapreg
in metaprop and metan under a broad range of conditions including, high over-dispersion and small meta-analysis. Conclusion metapreg is a flexible, robust and user-friendly tool employing a rigorous approach to evidence ...
Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
pooling absolute and relative accuracy. RESULTS: Twenty-two studies were included. Sensitivity and specificity estimates ranged from 54.2% (95% CI: 45.2-63.0) to 69.5% (95% CI:60.8-76.9) and from 82.8% (95% ...
Validation of the Flemish-Dutch diabetic foot ulcer scale short form (DFS-SF) questionnaire for diabetic foot ulcers
present in 31.7% of the patients, neuropathy in 88.5%. Most DFU were deep (93.2%) and showed signs of infection (60,6%). ICC of the different DFS- SF subscales ranged from 0.36 to 0.84. Cronbach’s alpha was ...
Accuracy of combinations of visual inspection using acetic acid or lugol iodine to detect cervical precancer: a meta-analysis.
less sensitive, but more specific, compared with VIA alone (relative sensitivity = 0.98, 95% CI 0.96-1.01; relative specificity = 1.04, 95% CI 1.02-1.05). The average PPV s were low (range 11-16%), ...
Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework.
presence/absence level also at the type-specific level in the whole population and in women over 30 years of age. Absolute clinical sensitivity and specificity of the PapilloCheck was high and ranged between 95.5% ...
Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework.
and values for the six individual types ranged from 0.78 (95% CI, 0.68 to 0.87) for HPV-52 to 0.96 (95% CI, 0.93 to 0.99) for HPV-16. These data suggest that the Onclarity assay offers applications for ...
Comprehensive control of human papillomavirus infections and related diseases.
challenges: costs of HPV prevention and medical care, the implementation of what is technically possible, socio-political resistance to prevention opportunities, and the very wide ranges of national economic ...
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
countries. Based on scarce data from the 12 countries, the high-risk HPV (hrHPV) prevalence among 5226 women with normal cytology ranged from 0.0% to 48.4%. In women with low-grade cervical lesions, the hrHPV ...
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
the start of screening ranging from 20 to 30 years and the estimated coverage ranging from a few percent to over 70%. At least one of the current HPV prophylactic vaccines is registered in all Central ...
Palliative care service use in four European countries: a cross-national retrospective study via representative networks of general practitioners.
Netherlands, 39% in Italy, 45% in Spain, and 47% in Belgium (p<.001). Specialist palliative care lasted a median (inter-quartile range) of 15 (23) days in Belgium to 30 (70) days in Italy (p<.001). Cancer ...